Garrison Asset Management, LLC Embecta Corp. Transaction History

Garrison Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 24, 2024	SELL	$15.0 - $22.17 $21,435 - $31,680	-1,429 Reduced 3.87%	35,466 $533,000
Q3 2023 Oct 23, 2023	SELL	$15.0 - $22.17 $15,510 - $22,923	-1,034 Reduced 2.83%	35,466 $534,000
Q2 2023 May 24, 2024	BUY	$21.6 - $30.69 $22,096 - $31,395	1,023 Added 2.85%	36,895 $796,000
Q2 2023 Aug 03, 2023	BUY	$21.6 - $30.69 $13,564 - $19,273	628 Added 1.75%	36,500 $773,000
Q1 2023 May 24, 2024	SELL	$23.07 - $32.77 $1,545 - $2,195	-67 Reduced 0.19%	35,872 $1.01 Million
Q1 2023 Apr 28, 2023	SELL	$23.07 - $32.77 $1,545 - $2,195	-67 Reduced 0.19%	35,872 $1.01 Million
Q4 2022 May 24, 2024	BUY	$25.29 - $35.48 $908,897 - $1.28 Million	35,939 New	35,939 $908,000
Q4 2022 Feb 07, 2023	SELL	$25.29 - $35.48 $3,970 - $5,570	-157 Reduced 0.43%	35,939 $909,000
Q3 2022 Oct 21, 2022	SELL	$24.0 - $33.42 $672 - $935	-28 Reduced 0.08%	36,096 $1.04 Million
Q2 2022 Aug 08, 2022	BUY	$24.78 - $33.36 $895,152 - $1.21 Million	36,124 New	36,124 $915,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.12B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Garrison Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Garrison Asset Management, LLC with notifications on news.